Cancer Oncology Testing Market, Global Outlook and Forecast 2024-2030
The global Cancer Oncology Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Fluorescence In Situ Hybridization Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cancer Oncology Testing include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Oncology Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Oncology Testing. This report contains market size and forecasts of Cancer Oncology Testing in global, including the following market information:
Global Cancer Oncology Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Cancer Oncology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Oncology Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Cancer Oncology Testing Market Segment Percentages, by Type, 2023 (%)
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Global Cancer Oncology Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Cancer Oncology Testing Market Segment Percentages, by Application, 2023 (%)
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Global Cancer Oncology Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Cancer Oncology Testing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Oncology Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Cancer Oncology Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Oncology Testing, market overview.
Chapter 2: Global Cancer Oncology Testing market size in revenue.
Chapter 3: Detailed analysis of Cancer Oncology Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Oncology Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
